Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
about
Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinicSantamarine Inhibits NF-кB and STAT3 Activation and Induces Apoptosis in HepG2 Liver Cancer Cells via Oxidative Stress.Perturbing mitosis for anti-cancer therapy: is cell death the only answer?Universal response in the RKO colon cancer cell line to distinct antimitotic therapies.MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor CellsCEP55 is a determinant of cell fate during perturbed mitosis in breast cancer
P2860
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
@en
type
label
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
@en
prefLabel
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
@en
P2093
Ailsa Bennett
Anthony Tighe
Louisa Nelson
Olivia Sloss
P2860
P356
10.1098/RSOB.160134
P577
2016-08-01T00:00:00Z